IDSA promotes a robust ID workforce of clinicians, researchers, and public health experts through a variety of efforts. In the public policy arena, the Society promotes the value of ID physicians and supports access to and appropriate reimbursements for infectious diseases services. IDSA also supports funding and policies that foster ID training.
Joint IDSA HIVMA Statement on the ID and HIV Workforce (PDF)
Joint IDSA/HIVMA testimony delivered at the House Energy and Commerce Committee Hearing "Supporting Tomorrow's Health Providers: Examining Workforce Programs Under the Public Health Service Act."
IDSA Outlines ID Policy Issues for Trump Transition Team (PDF)
IDSA outlines important ID policy issues for Vice President-elect Mike Pence, head of the Trump Transition Team.
IDSA Response to ID Match for Appointment Year 2016 (PDF)
Attracting the best and brightest to ID is a top priority for IDSA. The recent results of the ID Match for Appointment Year 2016, which were released on December 2, 2015, reaffirm the importance of the Society's ongoing efforts to promote the specialty.
IDSA Recommendations to Senate Finance Committee on MACRA (PDF)
IDSA recommendations to the Senate Finance Committee for the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, including the need for new infectious diseases (ID) quality measures and ways to better align new physician quality improvement programs with antibiotic stewardship and public health emergency preparedness. IDSA also highlighted the current undervaluation of the ID specialty and the steep decline in the number of physicians pursuing ID.
IDSA HIVMA Comments to HRSA on the ID Workforce and the Opioid Epidemic (PDF)
IDSA and HIVMA submitted recommendations to the Health Resources and Services Administration (HRSA) on building the ID workforce capacity necessary to respond to the opioid epidemic.
IDSA Letter to NIAID Re K Payline (PDF)
IDSA letter to NIAID regarding the final NIAID K award paylines for FY19. IDSA believes that the current baseline level of funding for K awardees if detrimental to the support of a strong ID physician-scientist pipeline.
IDSA Introduction to HHS Secretary Azar on ID Priorities (PDF)
IDSA congratulates new HHS Secretary Alex Azar on his appointment and highlights key issues facing patients and public health, including antimicrobial resistance, ID implications of the opioid epidemic, global health security, public health infrastructure and immunizations, research investments, and the ID physician workforce.
IDSA Comments RE HHS FY2018 - 2022 Strategic Plan (PDF)
IDSA comments on the Department of Health and Human Services (HHS) FY2018 - 2022 Strategic Plan.
IDSA Letter of Introduction to Surgeon General VADM Adams (PDF)
IDSA congratulates VADM Jerome Adams on his appointment as the nation's Surgeon General, the country's chief doctor and leader of the Public Health Commissioned Corps. IDSA requests a meeting with Dr. Adams to discuss key issues and opportunities to collaborate.
Joint IDSA HIVMA PIDS Comments to NIAID on Next Gen Researchers Initiative (PDF)
IDSA, HIVMA, and PIDS jointly submitted comments to NIAID on their Next Generation Research Initiative (NGRI).
Joint IDSA HIVMA PIDS Letter to NIH on Next Generation Researchers Initiative (PDF)
IDSA, the HIV Medicine Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS) wrote to the National Institutes of Health (NIH) on the importance of the Next Generation Researchers Initiative (NGRI).
IDSA Highlights Pressing ID Policy Issues for New HHS Secretary (PDF)
IDSA outlines a number of pressing ID policy priorities for new HHS Secretary Dr. Tom Price, including antimicrobial resistance, domestic and global public health programs, infrastructure, and preparedness, biomedical research and innovation, and ID physician workforce issues.
IDSA Leads Organizations in Advocacy for Implementation of NIH Physician Scientist Workforce Recommendations (PDF)
IDSA was joined by 35 other health groups in a letter to NIH Director Francis Collins requesting an update on efforts to bolster the physician-scientist workforce.
IDSA Responds to NIH Request for Information on Physician-Scientist Diversity (PDF)
IDSA commented on a NIH request for information on strategies to enhance diversity in the physician-scientist workforce, a recommendation from the NIH physician-scientist workforce report. IDSA enthusiastically supported the NIH’s effort, and highlighted the importance of strong NIH support of mentorship to underrepresented minorities.
IDSA, PIDS, and HIVMA Comments to NIH to Improve the Impact and Sustainability of Biomedical Research (PDF)
IDSA, PIDS, and HIVMA jointly commented on an NIH request for information on ways to optimize funding policies or other strategies that improve the impact and sustainability of biomedical research. The societies' listed areas of concern in administrative burden, workforce sustainability, and prioritization of research funding, and offered specific recommendations to improve them.
IDSA, PIDS, and HIVMA Comments on NIH Physician-Scientist Workforce Report (PDF)
IDSA, along with PIDS and HIVMA, jointly commented on the NIH Physician-Scientist Workforce Working Group report highlighting recommendations to improve the state of the physician-scientist workforce. While IDSA, PIDS, and HIVMA support many of the Working Group's findings, they highlight several concerns on specific recommendations.
Fact Sheet on ID Physician Workforce and Reimbursement (PDF)
Overview of issues related to the ID physician workforce, reimbursement, and evaluation and management (E/M) codes.
The Future Supply and Demand for Infectious Disease Physicians (PDF)
IDSA, in collaboration with the George Washington University Health Workforce Institute (GW-HWI), undertook a series of studies of the ID physician workforce in 2016. Based on the survey results and additional data, this report explores factors that are likely to influence the future supply and demand for ID physicians and presents projections of future supply and demand.